Stock listing

NASDAQ:MBIO Mustang Bio, Inc. Stock

Home listing (NASDAQ) of Mustang Bio, Inc.

Follow Mustang Bio, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:MBIO

$0.386 USD +0.016 (+4.3%)

Close on Oct 15, 2026

Ticker: NASDAQ:MBIO
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

Latest news

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

Jul 7, 2025

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

Mar 5, 2025

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

Feb 27, 2025

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Feb 11, 2025

Mustang Bio Announces Closing of $8 Million Public Offering

Feb 10, 2025

Mustang Bio Announces Pricing of $8 Million Public Offering

Feb 6, 2025

Mustang Bio Announces Reverse Stock Split

Jan 14, 2025

Mustang Bio Receives Positive Listing Determination from Nasdaq

Nov 12, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

Nov 7, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds Form 8 K

Oct 24, 2024

All Mustang Bio, Inc. news

Decks

Investor Presentation (February 2024)
Investor deck · 47 slides · February 2024
Investor Presentation (June 2017)
Investor deck · 27 slides · Jun 9, 2017
Investor Presentation (April 2016)
Investor deck · 20 slides · April 2016

Mustang Bio, Inc. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 123 in all · newest Jul 7, 2025 · oldest 2019
Decks: 3 decks · latest February 2024

Where Mustang Bio, Inc. is listed

Listing	Exchange	Country	Currency
NASDAQ:MBIO · Home listing · This page	NASDAQ	United States	USD
BOATS:MBIO	BOATS	United States	USD